Persistent Asset Partners’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Persistent Asset Partners's AQST Position: Q3 2026 in Review
Persistent Asset Partners opened a new position in Aquestive Therapeutics (AQST) in Q3 2026: 5,915 shares worth $27.4K. The stake represents 0.01% of the portfolio and ranks #543 among its holdings.
190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Persistent Asset Partners held 5,915 shares of Aquestive Therapeutics worth $27.4K as of Q3 2026.
- Aquestive Therapeutics was a new Persistent Asset Partners position in Q3 2026.
- Aquestive Therapeutics made up 0.01% of Persistent Asset Partners's portfolio in Q3 2026, its #543 holding.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.